Synkol is an EU-approved producer with a decade of expertise specializing in kind II rooster sternal collagen, marketed below the Hyacoll model.
“Hyacoll will develop into our flagship ingredient devoted to joint, bone and mobility well being throughout the promotional actions of your complete group, which now consists of Bart, Aronpharma, Greenvit and Synkol,” Rafal Pietruszynski, CEO at Greenvit, instructed NutraIngredients.
‘Broadening our expertise base’
Pietruszyński famous that investing in Synkol means getting into a brand new technological space.
Producing poultry-derived kind II collagen obtained from rooster sternal cartilage is “a sophisticated phase of the collagen market that requires experience in cartilage processing, managed enzymatic hydrolysis and purification to acquire a matrix wealthy in kind II collagen, chondroitin sulfate and hyaluronic acid,” he defined.
He famous that Synkols’ R&D background supplies broader laboratory and biotechnological competencies, which enhance Greenvit’s basis in extraction and standardization applied sciences for botanical uncooked supplies.
“Combining these strengths allows us to create extra complete ingredient platforms—for instance, linking HYACOLL with polyphenols to assist joints, mobility, post-workout restoration or wholesome ageing,” he mentioned. “That is exactly what we imply by broadening our expertise base.”
Advantages of kind II poultry collagen
Kind II collagen is the dominant structural protein in hyaline cartilage, which covers the ends of bones in joints, supporting clean motion and shock absorption. Its key position is to supply mechanical energy and resistance to put on, that are important for the right functioning of joints.
“Scientific analysis and meta-analyses verify that kind II collagen supplementation may also help cut back ache and enhance mobility in people with osteoarthritis (Simental-Mendía et al., 2025),” Pietruszynski mentioned, noting that it’s notably helpful in supporting older people and lively folks similar to athletes.
“Poultry-derived collagen obtained from pure rooster sternal cartilage naturally accommodates three key parts present in hyaline cartilage—kind II collagen, chondroitin sulfate and hyaluronic acid,” he mentioned. “These synergistic actives assist cartilage regeneration, stimulate endogenous collagen manufacturing and enhance joint construction and performance.”
As compared, Pietruszynski famous that bovine, porcine and marine collagens are primarily sorts I and III, utilized in nutricosmetic merchandise to assist pores and skin, hair and nail well being. Nevertheless, kind II collagen might also “present helpful results on pores and skin, hair and nails.”
“Though all collagens share structural features, variations in amino acid sequences and molecular construction result in distinctive organic results, which is why every kind of collagen is suited to totally different purposes,” he added.
Worldwide enlargement in 2026
With the worldwide collagen phase estimated to develop from roughly $5.9 billion in 2023 to $14.4 billion by 2033, Pietruszynski expects to see an more and more sturdy demand for EU-origin rooster sternal cartilage-derived kind II collagen.
“The market knowledge helps our forward-thinking transfer into specialised kind II collagen elements by the acquisition of Synkol and reinforces the message that Greenvit is evolving right into a broader, science-driven provider of high-value well being elements,” he mentioned.
In 2016, the corporate plans additional medical research on Hyacoll and its branded Aronvit extract, enlargement of its USA buyer base, and larger presence at main trade occasions.
“This may enable us to current a cohesive and highly effective picture of your complete group—Bart, Aronpharma, Synkol and Greenvit—at occasions similar to Vitafoods Europe 2026 in Barcelona, considerably enhancing the visibility and attractiveness of our world supply.”
